Premium
Equity Markets continued their positive start to this holiday-shortened week, finishing the day higher, with the Dow and S&P closing at new all-time highs. The Trump administration called on the General Services Administration to assist in the formal transition...
Premium
As speculated yesterday, Vaccine optimism boosted markets once again, which finished the day higher, led by Dow which gained 1.13%. We got more positive news on a vaccine. Operation Warp Speed Chief Moncef Slaoui said the U.S. hopes to begin administering Coronavirus...
Premium
U.S. Equity markets fell to end a choppy week on Friday, led by the Dow which closed lower by 0.75%. Indices were mixed throughout much of the day before a late-sell-off in the last 20 minutes of trading. There was positive vaccine news, after Pfizer and BioNTech said...
Premium
U.S. Equity Markets snapped a two-day losing streak, finishing the day higher, led by the NASDAQ which closed higher by 0.76%. U.S Indices sold off in the morning on worse-than-expected jobs data. Jobless Claims rose unexpectedly, marking the first increase in five...
Premium
U.S. Equity Markets bounced around as investors digested more vaccine headlines before selling off into the close in what turned out to be a volatile trading session. Both the S&P and Dow led the decline, closing lower by 1.16%. Markets initially rallied after we...
Premium
U.S. Equity Markets took a small breather after reaching new highs on Monday, finishing the day lower, led by the Dow which closed with a loss of 0.56%. Reimposed COVID-19 restrictions spooked investors. California Governor Gavin Newsom said the State was pulling the...
Premium
Vaccine optimism once again sent U.S. Equity Markets to all-time high, led by the Dow which closed just below 30,000 with a gain of 1.60%. Moderna said that the vaccine met its primary endpoint for efficacy. MRNA also said that its vaccine was 94.5% effective in the...
Premium
U.S. Equity Markets ended the week on a high note, finished the day higher, with the S&P and Dow both closing higher by 1.37%. Even though Coronavirus cases are still an area of concern, National Institute of Allergy and Infectious Diseases Director Dr. Anthony...
Premium
COVID-19 trends spooked Equity Markets, which finished the day lower, led by the Dow closing with a loss of 1.08% on what turned out to be another volatile trading session. U.S. case trends continued to hit record highs, bringing concerns that U.S individual States...
Premium
U.S. Equity Markets resumed their rally, finishing the day higher, led by the NASDAQ 100 which closed with a gain of 2.31%, while the Dow closed basically unchanged. Vaccine optimism was a driver again yesterday. National Institute of Allergy and Infectious Diseases...
Premium
U.S. Equity Markets took a breather yesterday, finishing the day mixed. The Dow closed 0.9% higher while the NASDAQ 100 continued Monday’s reversal, closing lower by 1.74%. After Monday’s positive vaccine news, focus shifted to how Pfizer and BioNTech would distribute...
Premium
U.S. Equity Markets surged on vaccine optimism, finishing the day higher but well off the intra-day highs. The Dow led the market higher closing 2.95% higher, while the NASDAQ 100 finished the session with a loss of 2.16%. Vaccine data was the big story. Pfizer and...
Premium
U.S Equity Markets closed mixed after bouncing around for most of Friday’s session. The Dow closed 0.24% lower while the NASDAQ 100 finished Friday with a gain of 0.11%, to have it’s best week since April at +7%. COVID-19 trends still weighed on investor sentiment....
Premium
U.S. Equity Markets continued their post-election rally, finishing the day higher, led again by the NASDAQ which gained 2.58%, while S&P closed 1.94% higher. Weekly Jobless Claims were in line with last week but remained below 1 million for the tenth straight...
Recent Comments